Type 2 Diabetes Patient Recruitment in New York

TheraNovex connects clinical trial sponsors with pre-screened, eligible Type 2 Diabetes patients across New York, including New York City, Buffalo, Rochester, and beyond.

Type 2 diabetes patient recruitment for glycemic control, cardiovascular outcome, and weight management trials.

Who qualifies: Adults with T2DM (HbA1c 7.0–10.5%) on stable background therapy, with or without cardiovascular disease.

Recruitment challenges: HbA1c range requirements and prior GLP-1/SGLT2 therapy eligibility criteria.

Our approach: Endocrinology and primary care referral networks with HbA1c pre-screening.

Our recruitment network spans all major metropolitan areas in New York, ensuring broad geographic coverage for your Type 2 Diabetes trial.